The FOXC2 Transcription Factor Promotes Melanoma Outgrowth and Regulates Expression of Genes Associated With Drug Resistance and Interferon Responsiveness

Conclusion: FOXC2 drives a tumor-promoting gene expression program in melanoma and is a prognostic indicator of patient response to multiple cancer therapies.

Source: Cancer Genomics and Proteomics - October 27, 2019 Category: Cancer & Oncology Authors: HARGADON, K. M., GYORFFY, B., STRONG, E. W., TARNAI, B. D., THOMPSON, J. C., BUSHHOUSE, D. Z., JOHNSON, C. E., WILLIAMS, C. J. Tags: Article Source Type: research